Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma

Anaplastic large cell lymphoma (ALCL) is a common subtype of the heterogeneous group of peripheral T-cell lymphomas, which is characterized by large pleomorphic cells with strong expression of CD30. Translocations involving ALK, the anaplastic lymphoma kinase gene, are associated with a favorable cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidegger, Simon, Beer, Ambros J, Geissinger, Eva, Rosenwald, Andreas, Peschel, Christian, Ringshausen, Ingo, Keller, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074177/
https://www.ncbi.nlm.nih.gov/pubmed/25018638
http://dx.doi.org/10.2147/OTT.S59795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074177/
https://www.ncbi.nlm.nih.gov/pubmed/25018638
http://dx.doi.org/10.2147/OTT.S59795

Ejemplares similares